Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-24 7:57 pm Sale |
2025-03-20 | 13D | ARS Pharmaceuticals, Inc. SPRY |
Flynn James E | 10,514,657 10.720% |
-563,270 (-5.08%) |
Filing History |
| 2024-06-17 8:47 pm Sale |
2024-06-13 | 13D | ARS Pharmaceuticals, Inc. SPRY |
Pratik Shah Living Trust dated June 15 2011 | 5,219,124 5.400% |
-1,332,900 (-20.34%) |
Filing History |
| 2024-06-11 7:18 pm Sale |
2024-06-04 | 13D | ARS Pharmaceuticals, Inc. SPRY |
Pratik Shah Living Trust dated June 15 2011 | 6,552,024 6.800% |
-3,604,180 (-35.49%) |
Filing History |
| 2024-03-29 4:14 pm Purchase |
2024-03-27 | 13D | ARS Pharmaceuticals, Inc. SPRY |
RA Capital Management, L.P. | 10,860,977 11.300% |
1,401,299 (+14.81%) |
Filing History |
| 2024-02-09 08:35 am Sale |
2024-02-08 | 13G | ARS Pharmaceuticals, Inc. SPRY |
FMR CORP | 1,202,315 1.252% |
-4,167,047 (-77.61%) |
Filing History |
| 2023-09-25 4:30 pm Purchase |
2023-09-21 | 13D | ARS Pharmaceuticals, Inc. SPRY |
RA Capital Management, L.P. | 9,459,678 9.900% |
2,700,000 (+39.94%) |
Filing History |
| 2023-09-01 4:15 pm Sale |
2023-08-29 | 13D | ARS Pharmaceuticals, Inc. SPRY |
Bell Robert G. | 4,313,965 4.500% |
-4,250,000 (-49.63%) |
Filing History |
| 2023-08-31 5:25 pm Purchase |
2023-08-29 | 13D | ARS Pharmaceuticals, Inc. SPRY |
RA Capital Management, L.P. | 6,759,678 7.070% |
5,017,492 (+288.00%) |
Filing History |
| 2023-02-14 4:35 pm Unchanged |
2022-12-31 | 13G | ARS Pharmaceuticals, Inc. SPRY |
NEXTECH VI ONCOLOGY SCSP | 1,910,029 2.000% |
0 (Unchanged) |
Filing History |
| 2023-02-13 4:32 pm Purchase |
2022-12-31 | 13G | ARS Pharmaceuticals, Inc. SPRY |
K2 PRINCIPAL FUND L.P. | 2,045,348 2.200% |
138,730 (+7.28%) |
Filing History |
| 2023-02-09 08:23 am Purchase |
2023-02-09 | 13G | ARS Pharmaceuticals, Inc. SPRY |
FMR CORP | 5,369,362 5.726% |
1,615,625 (+43.04%) |
Filing History |
| 2022-11-30 4:23 pm Sale |
2022-11-08 | 13D | ARS Pharmaceuticals, Inc. SPRY |
ORBIMED ADVISORS LLC | 7,788,510 8.300% |
-1 (-0.00%) |
Filing History |
| 2022-11-21 4:07 pm Purchase |
2022-11-08 | 13D | ARS Pharmaceuticals, Inc. SPRY |
Bell Robert G. | 8,563,965 9.100% |
8,563,965 (New Position) |
Filing History |
| 2022-11-18 5:06 pm Purchase |
2022-11-08 | 13D | ARS Pharmaceuticals, Inc. SPRY |
Flynn James E | 11,077,927 11.810% |
11,077,927 (New Position) |
Filing History |
| 2022-11-18 2:17 pm Purchase |
2022-11-08 | 13D | ARS Pharmaceuticals, Inc. SPRY |
Pratik Shah Living Trust dated June 15 2011 | 10,156,204 10.800% |
10,156,204 (New Position) |
Filing History |
| 2022-11-18 2:09 pm Purchase |
2022-11-08 | 13D | ARS Pharmaceuticals, Inc. SPRY |
Lowenthal Richard E | 7,422,432 7.900% |
7,422,432 (New Position) |
Filing History |
| 2022-11-18 1:58 pm Purchase |
2022-11-08 | 13D | ARS Pharmaceuticals, Inc. SPRY |
Tanimoto Sarina | 6,265,170 6.700% |
6,265,170 (New Position) |
Filing History |
| 2022-07-15 6:03 pm Purchase |
2022-07-13 | 13G | ARS Pharmaceuticals, Inc. SPRY |
K2 PRINCIPAL FUND L.P. | 1,906,618 5.410% |
1,906,618 (New Position) |
Filing History |
| 2022-02-14 4:33 pm Sale |
2021-12-31 | 13G | ARS Pharmaceuticals, Inc. SPRY |
Boxer Capital LLC | 0 0.000% |
-1,675,377 (Position Closed) |
Filing History |
| 2022-02-14 4:11 pm Unchanged |
2021-12-31 | 13G | ARS Pharmaceuticals, Inc. SPRY |
RA Capital Management, L.P. | 1,742,186 4.970% |
0 (Unchanged) |
Filing History |